INFEZIONE DA HBV E IMMUNODEPRESSORI OD IMMUNOMODULATORI. LE ULTIME EVIDENZE AGOSTO 2025 DA AISF & COLLEAGUESS ! ATTENZIONE RAGAZZE/I ! DA “DIGESTIVE&LIVER DISEASES” (FREE)

EPATOLOGIA, GASTROENTEROLOGIA, IBD, MEDICINA INTERNA, NEWSLETTER, ONCOLOGIA

Management of Hepatitis B virus infection in patients on treatment with immunosuppressants or immunomodulators: Position Paper of Associazione Italiana Studio del Fegato (AISF), Associazione Italiana di Oncologia Medica (AIOM), Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), Società Italiana di Reumatologia (SIR), Società Italiana Trapianti d’Organo (SITO), Società Italiana di Gastroenterologia (SIGE), Società Italiana…

SINDROME EPATORENALE OGGI: UNA GRANDE REVIEW DI VELEZ . DA “JASN” (AMERICAN SOCIETY OF NEPHROLOGY). NON FREE PURTROPPO. ANDATE A VEDERLO IN ESTESO!

EPATOLOGIA, EPATOLOGIA ONCOLOGICA, GASTROENTEROLOGIA, MEDICINA INTERNA, NEWSLETTER

Treating Hepatorenal Syndrome in the Current Era Velez, Juan Carlos  ABSTRACT Hepatorenal syndrome type 1 (HRS-1) is a severe form of acute kidney injury (AKI) that affects individuals with advanced cirrhosis and ascites. The main pillar of its pathogenesis is rooted on marked maladaptive renal vasoconstriction. Because of the lack of a gold standard, establishing…

L’INTESTINO RICORDA: L’USO ASSAI PREGRESSO DI FARMACI MODIFICA IL MICROBIOTA. UN GRANDE EDITORIALE SULL’ARTICOLO DELLA SOCIETA’ AMERICANA DI MICROBIOLOGIA SEGNALATO. DA “ASM” (FREE!)

GASTROENTEROLOGIA, MEDICINA DEI PROBIOTICI, NEWSLETTER

The gut remembers: the long-lasting effect of medication use on the gut microbiome Pamela Ferretti Growing evidence suggests that antibiotics and many human-targeted medications can alter the gut microbiome composition, but the persistence of these effects remains unclear. In their article, Aasmets and colleagues (O. Aasmets, N. Taba, K. L. Krigu, R. Andreson, et al., mSystems…

FARMACI PRESI ANCHE ANNI PRIMA MODIFICANO IL MICROBIOTA ! LA VARIABILITA’ INTER-INDIVIDUALE DEI TEST VA MEGLIO COMPRESA ! DA “ASM Journals” (SOCIETA’ AMERICANA DI MICROBIOLOGIA) (FREE!)

GASTROENTEROLOGIA, IBD, IBS, MEDICI DI FAMIGLIA, MEDICINA DEI PROBIOTICI, MEDICINA INTERNA, NEWSLETTER

A hidden confounder for microbiome studies: medications used years before sample collection Oliver Aasmets et al. Medication usage is a known contributor to the inter-individual variability of the gut microbiome. However, medications are often used repeatedly and for long periods, a notion yet unaccounted for in microbiome studies. Recently, we and others showed that not only…

LA INTOLLERANZA AL GLUTINE NON-CELIACA E’ SEGNALATA DA UN SOGGETTO SU 10 NEL MONDO! DA “GUT”

GASTROENTEROLOGIA, IBS, MEDICI DI FAMIGLIA, MEDICINA INTERNA, NEWSLETTER

Global prevalence of self-reported non-coeliac gluten and wheat sensitivity: a systematic review and meta-analysis Mohamed G Shiha et al. Abstract Background Non-coeliac gluten/wheat sensitivity (NCGWS) is characterised by gastrointestinal and extraintestinal symptoms related to gluten or wheat ingestion in individuals without coeliac disease or wheat allergy. Objective A systematic review and meta-analysis was conducted to estimate the…

LA GESTIONE DELL’ASCITE E DELLA IPONATREMIA NEL CIRROTICO: LE NUOVE LINEE GUIDA 2025 DELL’AGA. DA “GASTROENTEROLOGY” (FREE)

EPATOLOGIA, EPATOLOGIA ONCOLOGICA, MEDICINA INTERNA, NEWSLETTER

AGA Clinical Practice Update on the Management of Ascites, Volume Overload, and Hyponatremia in Cirrhosis: Expert Review Eric S. Orman et al. Abstract Description The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update (CPU) is to summarize the available evidence and offer expert Best Practice Advice (BPA) on the management of ascites, hepatic…